Annovis Bio, Inc. (ANVS)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q1-2026 | 8-K (2026-05-15) · 99.1 | 8-K (2026-03-16) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2025-11-13) · 99.1 | ||
| 10-Q | Q3-2025 | — | ||
| 10-Q | Q2-2025 | 8-K (2025-08-12) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-13) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-03-21) · 99.1 | 8-K (2024-11-12) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-08-15) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-05-13) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-04-03) · 99.1 | ||
| 10-K | FY-2023 | — | ||
| 10-Q | Q3-2023 | 8-K (2023-11-01) · 99.1 · 99.2 | ||
| 10-Q | Q2-2023 | — |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | ||
| Statements | ||
| Balance Sheets | ||
| Balance Sheets (P) | ||
| Statements of Operations | ||
| Statements of Operations and Comprehensive Loss | — |
|
| Statements of Changes In Stockholders' (deficit) Equity | ||
| Statements of Changes In Stockholders' Equity | — |
|
| Statements of Changes In Stockholders' Equity (deficit) | ||
| Statements of Cash Flows | ||
| Notes | ||
| Accrued Expenses | ||
| Commitments and Contingencies | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Fair Value Measurements | ||
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Nature of Business and Management's Plans | ||
| Nature of Business, Going Concern and Management's Plans | ||
| Net Loss Per Share | ||
| Pay Vs Performance Disclosure | ||
| Prepaid Expenses and Other Current Assets | ||
| Restatement of Previously Issued Unaudited Condensed Financial Statements | — |
|
| Segment Information | ||
| Stock-based Compensation | ||
| Stockholders' (deficit) Equity | ||
| Stockholders' Equity | — |
|
| Stockholders' Equity (deficit) | ||
| Subsequent Events | ||
| Summary of Significant Accounting Policies | ||